Associate Professor of Medicine, Associate Professor of Oncology, Johns Hopkins University School of Medicine
Hematology
Dr. Sophie Lanzkron, MD
|
|
Give Review
Sophie Lanzkron practices Hematology. She attended Albert Einstein College of Medicine of Yeshiva University. Dr. Sophie Lanzkron is a published doctor. She has 57 publications published. The most current publication "Cytokine induction of platelet activation." She is registered with Medicare and accepts Medicare payments.
Publications
- Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) Thalassemia genotypes.
- Multiple Levels of Suffering: Discrimination in Health-Care Settings is Associated With Enhanced Laboratory Pain Sensitivity in Sickle Cell Disease.
- An evaluation of Central sensitization in patients with sickle cell disease.
- Evidence gaps in the management of Sickle cell disease: A summary of needed research.
- Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.
- Impact of a dedicated infusion clinic for Acute management of adults with sickle cell pain crisis.
- Association of Sickle cell trait with chronic kidney disease and albuminuria in African Americans.
- Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
- Management of Sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
- Perceived Discrimination, Patient Trust, and Adherence to Medical Recommendations Among Persons with Sickle Cell Disease.
- Practice Guideline for Pulmonary Hypertension in Sickle Cell: Direct Evidence Needed before Universal Adoption.
- Attitudes toward clinical trials among patients with Sickle cell disease.
- Dental infections increase the likelihood of hospital admissions among adult patients with Sickle cell disease.
- Vasculopathy, inflammation and blood flow in leg ulcers of patients with sickle cell Anemia.
- Venous thromboembolism in adults with Sickle cell disease: a serious and under-recognized complication.
- A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing Sickle cell disease patients.
- The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell Anemia in the US and Europe.
- Sickle cell disease and venous thromboembolism: what the antiCoagulation expert needs to know.
- The impact of race and disease on Sickle cell patient wait times in the emergency department.
- Risk factors for death in 632 patients with sickle cell disease in the United States and United kingdom.
- Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor.
- Patent foramen ovale in patients with Sickle cell disease and stroke: case presentations and review of the literature.
- Hospitalization for pain in patients with Sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
- Nitric oxide for inhalation in the Acute treatment of sickle cell pain crisis: a randomized controlled trial.
- A video-intervention to improve clinician attitudes toward patients with Sickle cell disease: the results of a randomized experiment.
- Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with Sickle cell disease.
- Problematic hospital experiences among adult patients with Sickle cell disease.
- Religious coping and hospital admissions among adults with Sickle cell disease.
- The burden of emergency department use for Sickle-cell disease: an analysis of the national emergency department sample database.
- Hospital self-discharge among adults with Sickle-cell disease (SCD): associations with trust and interpersonal experiences with care.
- The association of provider communication with trust among adults with Sickle cell disease.
- Examining the effectiveness of hydroxyurea in people with Sickle cell disease.
- Time to recognize an overlooked trait.
- A Systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease.
- The course and correlates of high hospital utilization in Sickle cell disease: Evidence from a large, urban Medicaid managed care organization.
- The excess burden of stroke in hospitalized adults with Sickle cell disease.
- Health care provider attitudes toward patients with Acute vaso-occlusive crisis due to sickle cell disease: development of a scale.
- Hydroxyurea for sickle cell disease: a Systematic review for efficacy and toxicity in children.
- Provider barriers to hydroxyurea use in adults with Sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.
- Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.
- Hydroxyurea for the treatment of Sickle cell disease.
- Self-perceived loss of control and untreated dental decay in African American adults with and without Sickle cell disease.
- Hospitalization rates and costs of care of patients with sickle-cell Anemia in the state of Maryland in the era of hydroxyurea.
- The association between Sickle cell disease and dental caries in African Americans.
- High prevalence and correlates of low bone mineral density in young adults with Sickle cell disease.
- Polymerized human Hb use in Acute chest syndrome: a case report.
- The epidemiology, evaluation and treatment of stroke in adults with Sickle cell disease.
- Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents ...
- Prediction of onset and course of high hospital utilization in Sickle cell disease.
- Regulation of pml messenger-RNA expression in human breast-carcinoma Cells.
- Graft failure in a patient with Systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue.
- Ex-vivo expansion of bone marrow progenitor Cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.
- Hematopoietic stem Cell tracking in vivo: a comparison of short-term and long-term repopulating Cells.
- Cytokine induction of Platelet activation.
- Homing of long-term and short-term engrafting Cells in vivo.
- NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea.
Schools
Albert Einstein College of Medicine of Yeshiva University
University MD Med System
Johns Hopkins Hospital
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
Johns Hopkins University -
University of Maryland -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Drug Facts
| NPI NUMBER | 1740228444 | |
| NPPES Provider LastName | LANZKRON | |
| NPPES Provider FirstName | SOPHIE | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Hematology | |
| Total Claim Count | 90.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740228444 |
| Last Name Of The Provider | LANZKRON |
| First Name Of The Provider | SOPHIE |
| View All |
Similar Doctors
|
|
Dr. Jerry Spivak, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Meyer R. Heyman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher G. Kanakry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy S. Kimball, MD |
|
|
Dr. Satish P. Shanbhag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sein Aung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea C. Baines, MD |
|
|
Dr. Stacy L. Cooper, MD |
|
|
Dr. Kaushikkumar A. Shastri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nisha P. Soprey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heather A. Parsons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tara M. Robinson, MD |